Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Liam Davenport

    News

    ‘Frame running’ may help boost physical activity in MS

    Author:
    Liam Davenport
    Publish date: October 25, 2023

    ‘Frame running’ uses a three-wheeled frame with a saddle and body supports but no pedals to allow individuals with disabilities and balance...

    • Read More

    News

    Recombinant IL-2 shows potential in atopic dermatitis

    Author:
    Liam Davenport
    Publish date: October 25, 2023

    Rezpegaldesleukin is now being evaluated in a phase 2b study for moderate to severe atopic dermatitis, and a phase 2b trial for alopecia areata is...

    • Read More

    News

    Chemo-immunotherapy good, adding a PARP inhibitor better in endometrial cancer?

    Author:
    Liam Davenport
    Publish date: October 23, 2023

    Dr. Tan noted, the AtTEnd data "continue to validate practice-changing therapy for dMMR endometrial cancer patients."

    • Read More

    News

    Wearable devices show promise in monitoring multiple sclerosis

    Author:
    Liam Davenport
    Publish date: October 23, 2023

    Further analysis may allow the prediction of “relevant changes throughout the course of multiple sclerosis.”

    • Read More

    News

    Can some patients with esophageal cancer avoid surgery?

    Author:
    Liam Davenport
    Publish date: October 20, 2023

    About one-third of patients with esophageal cancer who have a compete response to neoadjuvant chemoradiotherapy may be able to avoid surgery....

    • Read More

    News

    Smart bracelet may predict mood changes in bipolar disorder

    Author:
    Liam Davenport
    Publish date: October 18, 2023

    Each sensor collects a sample every second, resulting in highly detailed and granular data.

    • Read More

    News

    MS-tailored weight loss program achieves meaningful results

    Author:
    Liam Davenport
    Publish date: October 18, 2023

    Weight loss “was associated with improved mobility, reduced fatigability, and improved physical quality of life.”

    • Read More

    News

    AI tool reveals MS drug interactions, offers safer options

    Author:
    Liam Davenport
    Publish date: October 13, 2023

    Deep learning–based methods are “useful” in screening for potential interactions both between drugs and with foods.

    • Read More

    News

    Ocrelizumab benefit confirmed in older patients with MS

    Author:
    Liam Davenport
    Publish date: October 13, 2023

    Lower rates of relapse were seen in older patients taking ocrelizumab, but the risk for relapse in this age group is low.

    • Read More

    News

    Confirmed: Intermittent use of benzodiazepines is the safest option

    Author:
    Liam Davenport
    Publish date: October 12, 2023

    “We’ve always known that there was a problem, but there haven’t been high-quality epidemiological studies like this that allowed us to say what...

    • Read More

    News

    Esketamine bests quetiapine for severe depression in head-to-head trial

    Author:
    Liam Davenport
    Publish date: October 12, 2023

    “These patients are not resistant, they just have resistance to monoaminergic drugs.”

    • Read More

    News

    Running vs. meds for depression: Is there a clear winner?

    Author:
    Liam Davenport
    Publish date: October 11, 2023

    Medication “generally had worse impact on body weight, heart rate variability, and blood pressure, whereas running therapy led to improved effect...

    • Read More

    News

    Exercise timing may dictate obesity, type 2 diabetes risk

    Author:
    Liam Davenport
    Publish date: September 21, 2023

    People who exercised in the morning had a lower body mass index than those who exercised at other times, even though they were more sedentary.

    • Read More

    News

    Many patients with NSCLC receive immunotherapy ‘indefinitely’ – Are they benefiting?

    Author:
    Liam Davenport
    Publish date: September 18, 2023

    Without “incontrovertible evidence” that immunotherapy should stop at 2 years, “many, many, many patients and clinicians are going to favor...

    • Read More

    News

    Proposed TNM update could shift staging for lung cancers

    Author:
    Liam Davenport
    Publish date: September 14, 2023

    Lung cancers, particularly those with T1 disease, could be reclassified into a different overall stage if proposed adaptations to the N and M...

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery